comparemela.com

Page 12 - Nasdaq Ilmn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bank of New York Mellon Corp Has $500 93 Million Stock Position in Illumina, Inc (NASDAQ:ILMN)

Bank of New York Mellon Corp lifted its holdings in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 6.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,648,935 shares of the life sciences company’s stock after purchasing an additional 225,074 shares […]

Clear Creek Financial Management LLC Invests $219,000 in Illumina, Inc (NASDAQ:ILMN)

Clear Creek Financial Management LLC purchased a new position in shares of Illumina, Inc. (NASDAQ:ILMN – Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 1,595 shares of the life sciences company’s stock, valued at approximately $219,000. Several other large investors also […]

Arlington Partners LLC Increases Position in Illumina, Inc (NASDAQ:ILMN)

Arlington Partners LLC lifted its holdings in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 33.8% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 736 shares of the life sciences company’s stock after purchasing an additional 186 shares during the period. Arlington Partners LLC’s holdings in Illumina were worth $101,000 at the end of […]

Handelsbanken Fonder AB Trims Stake in Illumina, Inc (NASDAQ:ILMN)

Handelsbanken Fonder AB reduced its position in Illumina, Inc. (NASDAQ:ILMN – Free Report) by 0.4% during the third quarter, Holdings Channel reports. The institutional investor owned 68,514 shares of the life sciences company’s stock after selling 292 shares during the quarter. Handelsbanken Fonder AB’s holdings in Illumina were worth $9,406,000 as of its most recent […]

Royal Bank of Canada Trims Illumina (NASDAQ:ILMN) Target Price to $258 00

Illumina (NASDAQ:ILMN – Free Report) had its price objective cut by Royal Bank of Canada from $260.00 to $258.00 in a report issued on Tuesday morning, Benzinga reports. They currently have an outperform rating on the life sciences company’s stock. Several other brokerages have also recently issued reports on ILMN. Stifel Nicolaus restated a buy […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.